Movement disorders:MRI新指标可有效鉴别帕金森和进行性核上麻痹

2022-06-15 Freeman MedSci原创

自动化的、经过验证的、可推广的磁共振生物标志物来区分PSP-P和PD

进行性核上性麻痹-帕金森病(PSP-P)和帕金森病(PD)之间的临床鉴别诊断可能具有挑战性,特别是在疾病发生后的头几年。PSP-P患者的临床表现主要是帕金森症,可以是不对称的,对左旋多巴有反应,与PD非常相似。PSP的唯一临床表现是眼球运动功能障碍,但核上垂直凝视麻痹可能在发病后19年才出现,因此诊断有时很困难。

图1: 论文封面图

迄今为止,一些影像学生物标志物已被证明有助于区分PSP和PD,而磁共振帕金森指数(MRPI)是最强大和最有力的标志之一。然而,这些影像学生物标志物大部分对PSP-理查德森综合征(PSP-RS)的诊断准确性很高,但未能准确区分PSP-P和PD患者,可能是因为这种较轻的PSP亚型的脑萎缩程度较低。

最近开发了新版本的MRPI(称为MRPI 2.0),以克服这一局限。除了MRPI测量的脑干结构(中脑、脑桥、小脑中段和上段)外,MRPI 2.0.还包括测量第三脑室(3 V)的宽度,这种脑结构在PSP患者中普遍增大,但在PD患者中却不存在。

初步结果显示,MRPI 2.0.能准确区分PSP-P患者和PD患者,但这一发现在最近的单中心研究中没有得到证实,该生物标志物区分PSP-P和PD的准确性较低,可能是由于手工测量的变异性和样本量小,因此提示需要自动计算MRPI 2.0.,并在较大的国际队列中进行验证性研究。

藉此,意大利University Magna Graecia的Andrea Quattrone等人,开发一种全自动的算法来计算MRPI 2.0.,并验证自动MRPI 2.0.在区分PSP-P患者和PD患者以及来自不同地区的两个大型独立队列中的表现。

他们招募了676名参与者:中心的训练队列(n = 346;43名PSP-P,194名PD,109名对照组)和一个国际研究小组的独立测试队列(n = 330;62名PSP-P,171名PD,97名对照组)。并开发了一种新的内部算法,用于MRPI 2.0的计算,并使用ROC曲线评估其在区分PSP-P和PD以及两个队列的对照受试者方面的表现。

他们发现:自动MRPI 2.0在区分PSP-P患者和PD患者以及对照组患者方面表现出色(ROC面积[AUC]=0.93[95%置信区间,0. 89-0.98]和AUC=0.97[0.93-1.00])和国际测试队列(PSP-P与PD相比,AUC=0.92[0.87-0.97];

 

图2:论文结果图

PSP-P与对照组相比,AUC=0.94[0.90-0.98]),表明结果具有普适性。自动MRPI 2.0也能准确区分PSP-P和PD的早期疾病(AUC = 0.91 [0.84-0.97])。自动和手动MRPI 2.0值之间有很强的相关性(r = 0.91,P < 0.001)。


该研究的重要意义在于提供了一个自动化的、经过验证的、可推广的磁共振生物标志物来区分PSP-P和PD。使用MRPI 2.0自动算法而不是人工测量,对不同中心的PSP-P患者的测量标准化很重要,对多中心研究和涉及不同地域患者的临床试验有积极影响。

 

原文出处:
Quattrone A, Bianco MG, Antonini A, et al. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson’s Disease. _Movement Disorders_. Published online April 11, 2022:mds.28992. doi:[10.1002/mds.28992](https://doi.org/10.1002/mds.28992)

 

 

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
    2023-05-07 anminleiryan

    #ERS#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
    2023-03-07 ligang4439
  3. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
    2022-11-05 cmj8wellington

    #Dis#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
    2023-03-01 仁心济世
  5. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1878536, encodeId=317218e853602, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sun May 07 22:01:24 CST 2023, time=2023-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976666, encodeId=21b019e66667f, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Tue Mar 07 13:01:24 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013896, encodeId=047f20138961f, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 05 13:01:24 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738128, encodeId=62c81e3812846, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Mar 01 17:01:24 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077695, encodeId=1b9920e7695de, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Dec 07 07:01:24 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784509, encodeId=adfc1e84509fc, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Tue Nov 08 03:01:24 CST 2022, time=2022-11-08, status=1, ipAttribution=)]
    2022-11-08 cmsvly

    #Disord#

    0

相关资讯

Nature:麻省理工学院冯国平团队揭示帕金森病治疗新靶点,靶向丘脑回路可挽救帕金森病运动和情绪缺陷

药物治疗(L-多巴)和脑深部电刺激是目前治疗帕金森病的主要手段,可以有效地改善肢体震颤等运动症状,但是对于非运动症状,例如情绪紊乱收效甚微。

iPSC疗法、新靶点、单细胞测序,帕金森病最新研究进展解读

帕金森病的治疗和诊断一直是十分热门的研究领域,最近帕金森病领域有了一些新的突破。通过这篇文章,我们一起了解下帕金森病领域的一些新发现、新进展。

Neurology:帕金森病患者的运动和非运动症状与健康相关的生活质量的关系

潜在的可治疗的运动和非运动症状,特别是神经精神症状,在PwPD的HRQOL的变化中占了很大一部分。

Movement Disorders:路易体病理和阿尔兹海默病理,如何影响男女的临床表型差异?

使用LB和AD生物标志物,即使在LB或AD病理不在临床预期之内,对于LB疾病和AD的准确临床诊断也是必要的。

Movement Disorders:特发性帕金森病患者尿液中Rab10磷酸化的升高

pT73-Rab10的水平较高与疾病进展的恶化有关。

European Radiology:帕金森病的SMwI MRI前瞻性多中心研究

最近,临床上开发了感光图加权成像(SMwI)技术以改善描绘含铁结构的信噪比和对比度-噪声比。最近的研究进一步表明,SMwI在评估3T下的黑质高浓度方面优于SW。

拓展阅读

BioScience Trends:帕金森病动物模型中的听力损伤可能与耳蜗传出纤维变化有关

帕金森病模型动物的耳蜗,尤其是其传出神经纤维系统,发生了早期且复杂的病理改变。

中医再亮剑!北京团队解密天麻钩藤饮:先救少突胶质细胞,再护神经元,帕金森“髓鞘-突触”双修复时代开启!

该研究首次将血清药物化学、单细胞转录组、网络药理学与类器官模型整合,阐明TGD“重塑神经元-少突胶质细胞互作”的新机制,为中医“祛风止颤”提供现代注解,也为全球PD复合药物研发贡献可复制的技术范式。

Lancet Neurology:硫唑嘌呤治疗早期帕金森病的概念验证试验,阴性主要终点下的性别差异信号与免疫调控启示

AZA-PD研究虽未支持硫唑嘌呤直接作为帕金森病的治疗选择,但它成功完成了概念验证,打开了通过调节外周免疫系统来干预帕金森病进程的研究大门。

2025帕金森病十大科学研究新进展 | 年终大盘点

神经科学论坛小编系统梳理2025年度最具影响力的十大科研进展,展示人类向帕金森病发起总攻的科学图景。

前沿快讯 | 情绪如何“震颤”?认知怎样“绊脚”?

安徽中医药大学王共强团队通过多模态研究,揭示消极情绪可加剧帕金森病、威尔森病患者震颤,认知负荷会恶化威尔森病患者步态,阐明情绪 - 认知 - 运动整合环路机制,为神经疾病精准干预提供新方向。

大脑“老化时钟”可预测帕金森病恶化速度

这种“异质性”为临床精准管理带来了巨大挑战,也使得旨在延缓甚至阻断疾病进程的新药临床试验举步维艰——为了在“平均”人群中检测出药物效果,往往需要招募成百上千的患者,耗时耗力且成功率低。

2025 共识建议:帕金森病认知障碍的诊断、评估和管理

国外神经内科相关专家小组(统称) · 2025-07-24